Organisation paid for research Program year 2025 Source: CMS Open Payments

Durant Stanko Johnson Cohen Et

Neither a doctor nor a teaching hospital

Research payments

$713,109

131 payments

Through program year 2025, Durant Stanko Johnson Cohen Et is reported as receiving $713,109 in research payments, across 131 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $8,875 4
2024 Research $64,670 22
2023 Research $299,783 68
2022 Research $339,781 37

Breakdown

Who paid Research payments · program years 2022–2025
  1. Genentech, Inc. $713,109 131 payments
Studies the money was for Research payments · program years 2022–2025
  1. Phase 2 of Ro7171009 in Ga $354,089 44 payments
  2. Belvedere $350,146 83 payments
  3. A Phase IV, Multicenter, Open-label Study to Assess Corneal Endothelial Cells in Patients With Neovascular Age-related Macular Degeneration Treated With the Port Delivery System With Ranibizumab (PDS) (Belvedere) $8,875 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record